T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients’ Outcomes
Authors:
- Nesrin I. TarbiahNTNesrin I. Tarbiah
- Nuha A. AlkhattabiNANuha A. Alkhattabi
- Abdullah J. AlsahafiAAAbdullah J. Alsahafi
- Hani S. AljahdaliHAHani S. Aljahdali
- Husam M. JoharjyHJHusam M. Joharjy
- Maryam H. Al-ZahraniMAMaryam H. Al-Zahrani
- Aliaa M. SabbanASAliaa M. Sabban
- Rana A. AlghamdiRARana A. Alghamdi
- Maha J. BalgoonMBMaha J. Balgoon
- Reham A. KhalifaRKReham A. Khalifa
Open Access
- 16 January 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (2) , 710
Abstract
Background: By the end of 2019, the COVID-19 pandemic spread all around the world with a wide spectrum of clinical presentations ranging from mild to moderate to severe or critical cases. T cell subtype dysregulation is mostly involved in the immunopathogenic mechanism. The present study aimed to highlight the role of monitoring T cell subtypes and their activation (expression of CD38) in COVID-19 patients compared to healthy subjects and their role in predicting severity and patients’ outcomes. Materials: The study involved 70 adult COVID-19 confirmed cases stratified into three groups: a mild/asymptomatic group, a clinically moderate group, and a clinically severe/critical group. Flow cytometry analysis was used for the assessment of CD3+ cells for total T cell count, CD4+ cells for helper T cells (Th), CD8+ cells for cytotoxic T cells (Tc), CD4+CD25+ cells for regulatory T cells (T reg), and CD38 expression in CD4+ T cells and CD8+ T cells for T cell activation. Results: A statistically significant difference was found between COVID-19 cases and healthy controls as regards low counts of all the targeted T cell subtypes, with the lowest counts detected among patients of the severe/critical group. Furthermore, CD38 overexpression was observed in both CD4+ and CD8+ T cells. Conclusion: Decreased T cell count, specifically CD8+ T cell (Tc), with T cell overactivation which was indicated by CD38 overexpression on CD4+ and CD8+ T cells had a substantial prognostic role in predicting severity and mortality among COVID-19 patients. These findings can provide a preliminary tool for clinicians to identify high-risk patients requiring vigilant monitoring, customized supportive therapy, or ICU admission. Studies on larger patient groups are needed.Keywords
Funding Information
- King Abdulaziz University (IFPRC-210-130-2020)
This publication has 60 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ declineBiochemical and Biophysical Research Communications, 2019
- The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD MetabolismCell Reports, 2017
- Manipulating the LUMO distribution of quinoxaline-containing architectures to design electron transport materials: Efficient blue phosphorescent organic light-emitting diodesOrganic Electronics, 2016
- Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infectionCell Death & Disease, 2016
- Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set PointImmunity, 2015
- Age-dependent dysregulation of innate immunityNature Reviews Immunology, 2013
- Networking at the Level of Host Immunity: Immune Cell Interactions during Persistent Viral InfectionsCell Host & Microbe, 2013
- Signals required for programming effector and memory development by CD8+ T cellsImmunological Reviews, 2006
- Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivoNature Medicine, 2001